SF3B1 and mucositis: Elucidating the impact of SF3B1 mutation in mucosal melanomas may provide more understanding of its role in tumorigenesis, and facilitate the development of new drugs (i.e. SF3B1 inhibitors) for mucosal melanomas with SF3B1 mutations.